Ginkgo biloba and Cashew Applications
Ginkgo biloba has been used medicinally for centuries, but contemporary research investigates its standardized extracts with considerably more precision, examining how compounds such as terpene trilactones and flavonoid glycosides move through the body and interact with neural tissue. The central interest lies in whether these extracts can slow or prevent cognitive decline, particularly in conditions like Alzheimer's disease, where oxidative stress and neuronal damage accumulate over time. Clinical and pharmacokinetic studies are working to determine effective dosing, bioavailability, and which molecular mechanisms actually account for observed neuroprotective effects — questions that remain genuinely contested. A parallel line of inquiry extends to cashew and other plant-derived compounds, exploring whether similar antioxidant profiles might offer comparable benefits for cognitive health.
- Works
- 25,022
- Total citations
- 231,241
- Keywords
- Ginkgo BilobaNeuroprotectiveDementiaAntioxidantCognitive ImpairmentAlzheimer's Disease
Top papers in Ginkgo biloba and Cashew Applications
Ordered by total citation count.
- Association of single nucleotide polymorphisms in the lens epithelium-derived growth factor (LEDGF/p75) with HIV-1 infection outcomes in brazilian HIV-1+ individuals↗ 7,028OA
- Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study↗ 4,354OA
- Clinical diagnostic criteria for dementia associated with Parkinson's disease↗ 3,033
- Antioxidant Activity and Phenolic Compounds in Selected Herbs↗ 2,875
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: <i>Movement</i> Disorder Society Task Force guidelines↗ 2,531OA
- Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases↗ 2,508OA
- Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030↗ 2,463
- The Parkinson Progression Marker Initiative (PPMI)↗ 1,907OA
- Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment↗ 1,857OA
- The Hawthorne Effect: a randomised, controlled trial↗ 1,720OA
- Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease↗ 1,559OA
- EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers↗ 1,423
Active researchers
Top authors in this area, ranked by h-index.